What is she best known for?
The fields of study she is best known for:
- Cancer
- Gene
- Internal medicine
Susan L. Neuhausen mainly focuses on Breast cancer, Internal medicine, Oncology, Cancer and Gynecology.
Her Breast cancer research is multidisciplinary, relying on both Odds ratio, Germline mutation, Genome-wide association study, Single-nucleotide polymorphism and Risk factor.
Her work in Internal medicine addresses issues such as Genotype, which are connected to fields such as Allele.
Susan L. Neuhausen combines subjects such as Estrogen receptor, Gene mutation and Prostate cancer with her study of Oncology.
Her studies examine the connections between Cancer and genetics, as well as such issues in Cancer research, with regards to Mutation.
Her research integrates issues of Family history and Genetic epidemiology in her study of Gynecology.
Her most cited work include:
- Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality (1012 citations)
- Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group (897 citations)
- Association analysis identifies 65 new breast cancer risk loci (661 citations)
What are the main themes of her work throughout her whole career to date?
Susan L. Neuhausen mostly deals with Breast cancer, Internal medicine, Oncology, Cancer and Genetics.
She interconnects Odds ratio, Genome-wide association study, Genotype, Single-nucleotide polymorphism and Gynecology in the investigation of issues within Breast cancer.
In her study, which falls under the umbrella issue of Gynecology, Hormone replacement therapy is strongly linked to Menopause.
Her work focuses on many connections between Internal medicine and other disciplines, such as Germline mutation, that overlap with her field of interest in Genetic testing.
Her study looks at the relationship between Oncology and fields such as Prostate cancer, as well as how they intersect with chemical problems.
Her Cancer study combines topics in areas such as Oophorectomy, Cancer research, Germline and PALB2.
She most often published in these fields:
- Breast cancer (60.80%)
- Internal medicine (50.13%)
- Oncology (44.00%)
What were the highlights of her more recent work (between 2018-2021)?
- Breast cancer (60.80%)
- Internal medicine (50.13%)
- Oncology (44.00%)
In recent papers she was focusing on the following fields of study:
Susan L. Neuhausen spends much of her time researching Breast cancer, Internal medicine, Oncology, Cancer and Genome-wide association study.
The Breast cancer study combines topics in areas such as Odds ratio, CHEK2, Germline, Medical genetics and Confidence interval.
Her work in Internal medicine tackles topics such as PALB2 which are related to areas like Penetrance.
Her Oncology research incorporates elements of Germline mutation, Prostate, Ovarian cancer, Single-nucleotide polymorphism and Prostate cancer.
Her Cancer study incorporates themes from Stage, Increased risk, Health equity, Socioeconomic status and Genetic testing.
The various areas that Susan L. Neuhausen examines in her Genome-wide association study study include Transcriptome, Susceptibility locus, Estrogen receptor and Linkage disequilibrium.
Between 2018 and 2021, her most popular works were:
- Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (335 citations)
- Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families (100 citations)
- Cancer health disparities in racial/ethnic minorities in the United States (68 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Breast cancer, Internal medicine, Oncology, Cancer and Genome-wide association study are her primary areas of study.
Her Breast cancer research incorporates themes from Odds ratio, Case-control study, Gene mutation, Confidence interval and Risk factor.
Prospective cohort study is the focus of her Internal medicine research.
Her Oncology study combines topics from a wide range of disciplines, such as Germline mutation, Genetic predisposition, Hazard ratio, Triple-negative breast cancer and Prostate cancer.
Cancer is the subject of her research, which falls under Genetics.
Her Genome-wide association study research includes elements of Transcriptome, Estrogen receptor and Medical genetics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
